<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.01460.033</object-id><label>Table 1.</label><caption><p>Sequence at position 40 of <italic>pre-miR-146a</italic> in primary human melanocytes, human melanoma cell lines and clinical samples</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.01460.033">http://dx.doi.org/10.7554/eLife.01460.033</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Human melanoma cell lines</th></tr></thead><tbody><tr><td>Cell Line</td><td/></tr><tr><td>&#8195;Melanocytes-1</td><td>CC</td></tr><tr><td>&#8195;Melanocytes-2</td><td>CC</td></tr><tr><td>&#8195;Yale SPORE melanocytes</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>&#8195;WM3918</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>&#8195;YUHEF</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>&#8195;YUVON</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>&#8195;YUSIV</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>&#8195;YUROB</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>&#8195;YUROL</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>&#8195;MeWo</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>&#8195;UCC257</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>&#8195;SKMEL28</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>&#8195;A375</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>&#8195;SKMEL5</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>&#8195;M14</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>&#8195;SKMEL19</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>&#8195;YULAC</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>&#8195;YUGEN8</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>&#8195;YUSAC2</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>&#8195;YURIF</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>&#8195;SKMEL103</td><td>C<bold><italic>G</italic></bold></td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th colspan="3">Matched clinical melanoma samples (Nevus/Primary)</th></tr><tr><th>Sample</th><th>Nevus (Type)<xref ref-type="table-fn" rid="tblfn1">*</xref></th><th>Primary Melanoma</th></tr></thead><tbody><tr><td>1</td><td>C<bold><italic>G</italic></bold> (IM)</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>2</td><td>CC (C)</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>3</td><td>C<bold><italic>G</italic></bold> (C)</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>4</td><td>C<bold><italic>G</italic></bold> (C)</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>5</td><td>C<bold><italic>G</italic></bold> (LJ)</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>6</td><td>C<bold><italic>G</italic></bold> (IM)</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>7</td><td>C<bold><italic>G</italic></bold> (IM)</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>8</td><td>C<bold><italic>G</italic></bold> (LJ)</td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>9</td><td>C<bold>G (</bold>IM<bold>)</bold></td><td>C<bold>G</bold></td></tr><tr><td>10</td><td>CC (C)</td><td>C<bold>G</bold></td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th colspan="3">Matched Clinical Melanoma Samples (Primary/Metastatic)</th></tr><tr><th>Sample</th><th>Primary Melanoma</th><th>Metastatic Melanoma</th></tr></thead><tbody><tr><td>1</td><td>C<bold><italic>G</italic></bold></td><td><bold><italic>GG</italic></bold></td></tr><tr><td>2</td><td>C<bold><italic>G</italic></bold></td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>3</td><td>C<bold><italic>G</italic></bold></td><td><bold><italic>GG</italic></bold></td></tr><tr><td>4</td><td>C<bold><italic>G</italic></bold></td><td>C<bold><italic>G</italic></bold></td></tr><tr><td>5</td><td>CC</td><td><bold><italic>GG</italic></bold></td></tr><tr><td>6</td><td>C<bold><italic>G</italic></bold></td><td><bold><italic>GG</italic></bold></td></tr><tr><td><bold><italic>7</italic></bold></td><td><italic>C</italic><bold><italic>G</italic></bold></td><td><bold><italic>GG</italic></bold></td></tr><tr><td>8</td><td>CC</td><td>CC</td></tr><tr><td>9</td><td>C<bold>G</bold></td><td>C<bold>G</bold></td></tr><tr><td>10</td><td>C<bold>G</bold></td><td>C<bold>G</bold></td></tr><tr><td>11</td><td>CG</td><td>C<bold>G</bold></td></tr><tr><td>12</td><td>CG</td><td><bold>GG</bold></td></tr><tr><td>13</td><td>CG</td><td><bold>GG</bold></td></tr><tr><td>14</td><td>CG</td><td><bold>GG</bold></td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>*</label><p>IM, Intradermal melanocytic nevus. C, Compound nevus. LJ, Lentigenous juctional nevus. Samples highlighted in gray indicate C-to-G mutation during melanoma progression.</p></fn></table-wrap-foot></table-wrap>